Alkermes (ALKS) Other Non-Current Liabilities (2011 - 2026)

Alkermes' (ALKS) quarterly Other Non-Current Liabilities came in at $109.5 million in Q1 2026, up 86.05% year-on-year from $58.9 million in Q1 2025, and up 92.93% on a QoQ basis from $56.8 million in Q3 2025.

Alkermes (ALKS) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Other Non-Current Liabilities data on file, last reported at $109.5 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 86.05% year-over-year to $109.5 million in Q1 2026; TTM through Mar 2026 was $109.5 million, a 86.05% increase from a year earlier, with the FY2024 full-year figure at $56.0 million, up 12.31% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $109.5 million, up from $56.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for ALKS reached as high as $109.5 million in Q1 2026 and fell as low as $42.4 million in Q4 2022.
  • Historically, Other Non-Current Liabilities has averaged $53.9 million across 5 years, with a median of $49.4 million in 2023.
  • Across the five-year window, Other Non-Current Liabilities fell 2.9% in 2022 and jumped 86.05% in 2026, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $42.4 million in 2022, then advanced by 17.68% to $49.9 million in 2023, then advanced by 12.31% to $56.0 million in 2024, then gained by 1.31% to $56.8 million in 2025, then jumped by 92.93% to $109.5 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $109.5 million in Q1 2026, $56.8 million in Q3 2025, and $56.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 109.49 Mn
Sep 30, 2025 56.75 Mn
Jun 30, 2025 56.05 Mn
Mar 31, 2025 58.85 Mn
Dec 31, 2024 56.02 Mn
Sep 30, 2024 52.63 Mn
Jun 30, 2024 48.29 Mn
Mar 31, 2024 48.96 Mn
Dec 31, 2023 49.88 Mn
Sep 30, 2023 53.62 Mn
Jun 30, 2023 48.22 Mn
Mar 31, 2023 48.49 Mn
Dec 31, 2022 42.38 Mn
Sep 30, 2022 42.86 Mn
Jun 30, 2022 45.21 Mn
Mar 31, 2022 43.91 Mn
Dec 31, 2021 43.65 Mn
Sep 30, 2021 32.12 Mn
Jun 30, 2021 36.32 Mn
Mar 31, 2021 36.27 Mn